Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ombretta Marano"'
Autor:
A. Diana, Giacomo Cartenì, Sabino De Placido, Ombretta Marano, Fortunato Ciardiello, Raffaele Addeo, Michele Orditura, Rossella Lauria, Antonio Febbraro, Pasquale Incoronato, Ferdinando Riccardi, Carmela Mocerino, Francesco Nuzzo, G. Colantuoni
Publikováno v:
Molecular and Clinical Oncology
Exemestane (Exe) in combination with Everolimus (Eve) represents an important treatment option for patients diagnosed with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2‑) metastatic breast cancer (MBC), wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e862a8e8e4ae11876d809f2114d5493
http://hdl.handle.net/11588/789589
http://hdl.handle.net/11588/789589
Autor:
Carmine Pizza, Vincenzo Altieri, Giampaolo Tortora, Ombretta Marano, Riccardo Autorino, Adele D’Alessio, Michele De Laurentiis, Angelo Raffaele Bianco, Sisto Perdonà, Giuseppe Di Lorenzo, Giuseppe Cancello, Sabino De Placido
Publikováno v:
European Urology. 46:712-716
Background: The current study investigated the clinical benefit, the impact on biochemical and objective response and tolerability of weekly docetaxel with vinorelbine (VIN-DOX) in symptomatic patients with hormone refractory prostate cancer (HRPC).
Autor:
Riccardi, Ferdinando1, Colantuoni, Giuseppe2, Diana, Anna3 annadiana88@gmail.com, Mocerino, Carmela1, Cartenì, Giacomo1, Lauria, Rossella4, Febbraro, Antonio5, Nuzzo, Francesco6, Addeo, Raffaele7, Marano, Ombretta8, Incoronato, Pasquale9, De Placido, Sabino4, Ciardiello, Fortunato3, Orditura, Michele3
Publikováno v:
Molecular & Clinical Oncology. 2018, Vol. 9 Issue 3, p255-263. 9p.